| Financial Year |
March 31 2023 |
| Monetary Funds |
791,968,723.81 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
1,200,000.00 |
| Accounts Receivable |
157,783,165.59 |
| Advances to Suppliers |
8,872,606.10 |
| Other Receivables |
37,818,320.25 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
701,918,460.55 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
81,410,422.35 |
| Total Current Assets |
1,782,383,152.60 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
571,250,995.23 |
| Investment Properties |
7,218,228.04 |
| Fixed Assetes |
3,335,698,603.59 |
| Under-construction Projects |
419,771,187.95 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
608,959,617.83 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
16,318,645.39 |
| Deferred Income Tax Assets |
75,759,735.36 |
| Other Non-Current Assets |
1,664,000.00 |
| Sub-Total of Non-Current Assets |
5,170,316,079.71 |
| Total Assets |
6,952,699,232.31 |
| Short-Term Loans |
320,314,236.12 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
287,364,013.76 |
| Accounts Received In Advance |
1,107,226.09 |
| Employee Compensation Payable |
34,706,400.14 |
| Taxes Payable |
49,585,845.73 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
157,934,442.38 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
280,426,773.68 |
| Other Current Liabilities |
1,187,143.86 |
| Sub-Total of Current Liabilities |
2,404,496,129.41 |
| Long-term Loans |
620,212,026.71 |
| Bonds Payable |
301,552,338.22 |
| Long-Term Accounts Payable |
89,523,026.84 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
4,721,750.86 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
1,639,548,052.30 |
| Total Liabilities |
4,044,044,181.71 |
| Paid-In Capital(Or Share Stock) |
352,995,758.00 |
| Capital Surplus |
1,152,379,387.02 |
| Surplus Reserve |
116,994,245.64 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
646,946,418.01 |
| Minority Stockholder's Interest |
648,054,214.36 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,260,600,836.24 |
| Owner's Equity（Stockholder's Equity） |
2,908,655,050.60 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
6,952,699,232.31 |
